IP Library Granted Patent US 11,413,270
Granted Patent B2
US 11,413,270 · App. 16/908,195 · Granted Aug 16, 2022

Method for the treatment of pancreatitis

Inventors: Heon Jong Lee (Incheon-si, KR); Hoe Yune Jung (Pohang-si, KR); In-Kyu Lee (Daegu, KR); Jae-Han Jeon (Daegu, KR); Sung Jin Cho (Daegu, KR)
Assignee: NOVMETAPHARMA CO., LTD.
A61K31/397A61K31/396A61K31/403A61K31/407A61K31/4025A61K31/4192A61K31/4453A61K31/454A61K31/4525A61K31/495A61K31/5375A61P1/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,413,270
App. No.
16/908,195
Granted
Aug 16, 2022
Kind
B2
Abstract

A composition for preventing and/or treating pancreatitis and a method of prevention and/or treatment of pancreatitis are disclosed. The composition include an aryl ethene compound, a pharmaceutically acceptable salt thereof, or a solvate thereof, as an active ingredient. The method includes administering the aryl ethene compound, an isomer, a pharmaceutically acceptable salt thereof, or a solvate thereof, in an effective amount to a subject in need thereof.

Claims (12)

1. A method for treating and/or preventing pancreatitis in a subject in need thereof, comprising administering to the subject an effective amount of a compound,

wherein the compound is selected from the following compounds:

or an isomer, a pharmaceutically acceptable salt thereof, or a solvate thereof.

2. The method of claim 1 , wherein the pancreatitis is acute pancreatitis.

3. The method of claim 1 , wherein the subject is a mammal.

4. The method of claim 3 , wherein the mammal is human.

5. The method of claim 1 , wherein the compound is (E)-5-(4-hydroxyphenyl)-5-(4-(4-isopropylpiperazin-1-yl)phenyl)-4-phenylpent-4-en-1-ol of the following chemical formula:

or an isomer, a pharmaceutically acceptable salt, or a solvate thereof.

6. A method for preventing and/or treating pancreatitis in a subject in need thereof, comprising administering an effective amount of (E)-5-(4-hydroxyphenyl)-5-(4-(4-isopropylpiperazin-1-yl)phenyl)-4-phenylpent-4-en-1-ol of the following chemical formula:

or a therapeutically acceptable salt thereof

to the subject.

7. The method of claim 6 , wherein the pancreatitis is acute pancreatitis.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2022
From: LEE, HEON JONG; JUNG, HOE YUNE; LEE, IN-KYU; JEON, JAE-HAN; CHO, SUNG JIN; CHANDA, DIPANJAN
To: NOVMETAPHARMA CO., LTD.
Reel/Frame 061339/0253 →
MERGER Recorded Apr 7, 2022
From: NOVMETAHEALTH CO., LTD.
To: NOVMETAPHARMA CO., LTD.
Reel/Frame 060242/0960 →
Continuity (1)
Related Publication 20210393583A1 · Dec 23, 2021